Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout

Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
Gilmer VanegasJean-Claude Le Mével

Abstract

The QT interval of the electrocardiogram (ECG) is a measure of the duration of the ventricular depolarization and repolarization. In fish as in human, the QT interval is positively correlated with the RR interval of the ECG, a measure of the cardiac cycle length. Urotensin II (UII) is a neuropeptide that has been highly conserved from fish to human, and UII and its receptor (UT) are expressed in cardiovascular tissues including the heart. Although UII exerts potent cardiovascular actions, its possible effects on the QT interval have never been investigated. The goal of the present study was to provide insight into the potential effect of UII on the QT interval in an established in vivo trout model. To this end, the effects of UII on dorsal aortic blood pressure (PDA), RR, QT intervals and corrected QT (QTc) for RR interval, were investigated after intra-arterial (IA) injection of 5, 50 and 100 pmol UII. The effects of UII were compared to those of two structurally UII-related peptides (URPs), URP1 and URP2, and to those of arginine vasotocin (AVT), homolog of the mammalian arginine vasopressin. IA injection of vehicle or 5 pmol UII had no effect on the various parameters. At the 50-pmol dose, UII evoked its usual increase in PD...Continue Reading

References

Oct 30, 1992·Biochemical and Biophysical Research Communications·J M ConlonH Vaudry
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D PearsonH A Bern
Nov 1, 1982·The American Journal of Cardiology·K F BrowneE N Prystowsky
Oct 1, 1994·General and Comparative Endocrinology·D E Arnold-Reed, R J Balment
Apr 22, 1996·FEBS Letters·A K FilippovD A Brown
Nov 24, 1999·Lancet·S Viskin
Feb 26, 2000·Trends in Pharmacological Sciences·A P Davenport, J J Maguire
Jan 13, 2001·British Journal of Pharmacology·F D RussellD M O'Brien
Mar 15, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Matti VornanenAntti Nurmi
Aug 9, 2003·Physiological and Biochemical Zoology : PBZ·Claudio AgnisolaEdwin W Taylor
Dec 4, 2003·British Journal of Pharmacology·Riccardo PatacchiniCarlo Alberto Maggi
Oct 7, 2004·Pharmacology & Therapeutics·Fraser D Russell
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
May 2, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M HassinenM Vornanen
May 30, 2008·Journal of Pharmacological and Toxicological Methods·Hugo M VargasJean-Pierre Valentin
Apr 28, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bryan RossAdel Giaid
Jun 18, 2010·European Journal of Pharmacology·Jana Kmecova, Jan Klimas
Jul 17, 2010·Annals of the New York Academy of Sciences·Hubert VaudryJérôme Leprince
Dec 3, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Shigenori NobataYoshio Takei
Jan 6, 2011·The Journal of Pharmacology and Experimental Therapeutics·Yusheng QuHugo M Vargas
May 31, 2011·Acta Pharmacologica Sinica·Ping-zheng ZhouZhao-bing Gao
Nov 11, 2011·The Journal of Experimental Biology·David H EvansPatrick Buchanan
Nov 2, 2012·Frontiers in Endocrinology·Jean-Claude Le MévelJ Michael Conlon
Jan 15, 2013·General and Comparative Endocrinology·Hervé TostivintIsabelle Lihrmann
Jan 1, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Angelica Lopez-IzquierdoMartin Tristani-Firouzi
Dec 3, 2014·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Marc KermorgantJean-Claude Le Mével
Jul 29, 2015·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Minna HassinenMatti Vornanen

❮ Previous
Next ❯

Citations

Mar 13, 2021·General and Comparative Endocrinology·Pengxin JiangWeiqun Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
Marc KermorgantJean-Claude Le Mével
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Nagi MimassiJean-Claude Le Mével
Annals of the New York Academy of Sciences
Nagi MimassiJean-Claude Le Mével
© 2022 Meta ULC. All rights reserved